Genmab A/S (GMAB)
Genmab A/S stock analysis and opportunity scoring
$37.00
As of Oct 16
↓ -2.17%
Genmab A/S (GMAB) at a glance
Genmab A/S (GMAB) is a publicly traded company tracked by MKD Intelligence.
GMAB last traded at $37.00 down 2.17% on the session as of 2026-10-16.
MKD Intelligence assigns GMAB a composite opportunity score of 49 out of 100, indicating mixed conditions across trend, momentum and volume factors.
The risk score for GMAB is 56 out of 100 (moderate), where a higher number means greater expected volatility.
Price History
High
$38.48
Low
$34.55
Period
Oct 16 - Sep 18 (21d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
No recent news available.
Upcoming Events
Data as of Oct 19
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.